Nadim Ahmed - 18 Oct 2021 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
18 Oct 2021
Net transactions value
$0
Form type
4
Filing time
20 Oct 2021, 16:35:10 UTC
Next filing
07 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Award $0 +2,710,000 $0.000000 2,710,000 18 Oct 2021 Common Stock 2,710,000 $21.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 2,710,000 shares of the Issuer's Common Stock, which shall vest on a pro-rated basis commencing on October 18, 2021, with 1/48 of the shares vesting on a monthly basis over four years, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.